BofA raises Citi stock price target to $150 on earnings beat

Citigroup reported Q1 2026 core EPS of $3.06, topping BofA’s $2.61 forecast and consensus at roughly $2.63-$2.65, while revenue of $24.6 billion also beat expectations of $23.51 billion. BofA raised its price target to $150 from $140 and kept a Buy rating, citing stronger growth and profitability outlooks; it lifted FY2026 EPS to $10.79 from $10.49. Higher credit costs from a $350 million reserve build offset some of the beat, but the stock remains near its 52-week high at $129.58.

Analysis

C’s move is less about one-quarter upside and more about a higher-quality earnings trajectory finally becoming visible enough for the market to re-rate tangible book. The important second-order effect is that a larger reserve build in a beat quarter signals management is leaning into conservatism, which lowers the odds of a future negative surprise and makes the franchise look less like a “value trap” and more like a compounding bank with operating leverage.

The bigger implication is relative: if Citi can keep delivering double-digit EPS growth while still trading below the broader mega-bank multiple set, the next leg of performance is likely to come from multiple expansion rather than further estimate revisions. That creates pressure on peers with similar restructuring narratives but weaker execution, especially banks whose return-on-tangible-equity progress is slower and whose credibility with the Street is already fully priced.

A near-term pullback would not necessarily invalidate the thesis; it would likely reflect profit-taking after a crowded run and skepticism that the pace of outperformance is durable. The real risk is that the reserve build was being read as forward-looking caution tied to consumer credit and portfolio mix, so if macro data softens over the next 1-2 quarters, investors may shift from rewarding cleaner earnings to worrying about credit normalization. That is where the stock becomes a sentiment trade, not a fundamentals trade.

The most interesting contrarian angle is that the market may still be underestimating how much operational simplification and capital return capacity can matter once confidence in earnings quality is restored. If management keeps executing, the stock can continue to rerate even without heroic growth assumptions; if not, the current multiple is close enough to fair value that the downside is more about time decay than outright thesis break.

Key Decisions for Investors

• Stay long C into the next 1-2 earnings prints, but size as a rerating trade rather than a momentum chase; upside is still driven by multiple expansion toward peers, while downside is limited unless credit trends deteriorate materially.
• Use any 3-5% post-earnings pullback to add to C, with a 3-6 month horizon and a risk/reward profile skewed 2:1 to the upside if tangible book multiple keeps converging toward peers.
• Pair trade: long C / short a lower-quality bank with similar restructuring optics but weaker execution and slower return-on-equity improvement; this isolates the market’s willingness to pay for credibility versus mere cost-cutting.
• For event-driven exposure, buy C call spreads 2-4 months out on dips rather than outright stock if you expect another analyst revision cycle; the thesis is multiple expansion, so convexity is efficient.
• Trim or hedge if the next macro/credit data start to show consumer delinquencies rolling over, since the reserve-build narrative can flip from prudence to warning sign quickly.